Literature DB >> 5316358

Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment.

D Alarcón-Segovia, E Fishbein, H Alcalá.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5316358     DOI: 10.1002/art.1780140610

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 2.  Drug-induced lupus erythematosus: an update on drugs and mechanisms.

Authors:  Ye He; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-09       Impact factor: 5.006

3.  Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.

Authors:  K Carr; J A Oates; A S Nies; R L Woosley
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

4.  Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring.

Authors:  J Lewalter; U Korallus
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

Review 5.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 6.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 7.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

8.  HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.

Authors:  Neesha Rockwood; Graeme Meintjes; Maxwell Chirehwa; Lubbe Wiesner; Helen McIlleron; Robert J Wilkinson; Paolo Denti
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.